Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy
Condition(s):EpilepsyLast Updated:August 23, 2022Recruiting
Include Studies Not Open or Pending
Condition(s):EpilepsyLast Updated:August 23, 2022Recruiting
Condition(s):Eating Disorders; Binge Eating; Purging (Eating Disorders); Bulimia Nervosa; Anorexia Nervosa, AtypicalLast Updated:October 12, 2023Recruiting
Condition(s):Breast Cancer; Breast NeoplasmLast Updated:March 6, 2024Not yet recruiting
Condition(s):Breast Cancer FemaleLast Updated:May 23, 2023Recruiting
Condition(s):OutcomesLast Updated:April 27, 2023Recruiting
Condition(s):Clonal Cytopenia of Undetermined Significance; Myelodysplastic SyndromesLast Updated:February 21, 2024Recruiting
Condition(s):Spinal Cord InjuriesLast Updated:November 8, 2023Recruiting
Condition(s):Esophageal Cancer; Kidney Cancer; Larynx Cancer; Liver Cancer; Lung Cancer; Digestive Organs–Cancer; Intrathoracic–Cancer; Respiratory Organs–Cancer; Pancreas Cancer; Small Intestine Cancer; Stomach Cancer; Colon Cancer; Rectal CancerLast Updated:March 20, 2024Recruiting
Condition(s):Alzheimer DiseaseLast Updated:November 29, 2023Recruiting
Condition(s):Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma; Transformed B-Cell Lymphoma; Follicular Lymphoma Grade 3BLast Updated:January 9, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.